You have read all your free articles, to continue reading subscribe to read the rest of this content.
Immunicum has announced that Sven Rohmann has been appointed Chief Executive Officer (CEO) effective immediately. Bringing 30 years of industry experience from biotechnology and pharmaceutical companies as well as life science investment and company sale and acquisition experience, Rohmann will bAlready a subscriber Login You have read all your free…
Nanoform Finland will convene an extraordinary general meeting (EGM) on November 17 to elect Jeanne Thoma as a new board member. “Following the successful completion of our clinical trial and commercial expansion, we’ve reached an exciting point in Nanoform’s growth trajectory and are deligAlready a subscriber Login You have read…
Scandinavian Biopharma is expanding by hiring a PhD in cell- and molecular biology. Teresa Holmlund has joined the company. She has a PhD in cell and molecular biology and ten years of academic research experience studying molecular mechanisms in mitochondrial disease, cancer and severe congenitaAlready a subscriber Login You have…
Per Alfredsson has been appointed new Chief Executive Officer of AstraZeneca AB. Per Alfredsson took over the role after Katarina Ageborg on January 9th. He will maintain his role as Senior Vice President for Biologics Operations and will continue to lead the company's global production network fAlready a subscriber Login…
